About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

TERMINATEDPhase 4NCT03497598

Preventing Recurrent Urinary Tract Infections With α-D-mannose

In this trial, women with history of recurrent urinary tract infections (UTIs) will be followed over the course of 6 months. The women will be randomized either to D- Mannose or Placebo. The primary ...

Lead sponsor: Kantonsspital Aarau•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Kantonsspital Aarau

Age

18 - No limit years

Sex

FEMALE

Healthy Volunteers

No

Inclusion Criteria

•Women
•≥ 3 UTIs within the last 12 months or ≥ 2 UTIs within the last 6 months;
•Laboratory urine culture: \<103 CFUs
•Age \> 18 years

Exclusion Criteria

•UTIs ≥ 12 within 1 year
•Pregnancy or Lactation
•Immune disease
•Lactose intolerance
•Urinary tract anomaly
•Systemic infection
•Newly started hormone therapy within the last 6 months
•Antibiotic prophylaxis within the last 6 months
•α-D-mannose intake within the last month
•Use of catheters
•Diabetes mellitus
•Participation to other studies

Related studies

Antibiotic Irrigation and Suction Ureteral Access Sheath in RIRS

NCT07655050 · Kidney Calculi, Urolithiasis, and more

Double Voiding and Post-transplant UTI

NCT05711446 · Urinary Tract Infections, Kidney Transplant; Complications

RECRUITINGPhase 2

Antibiotic Prophylaxis for Neurogenic Bladder Botox

NCT04791579 · Neurogenic Bladder, Post-operative Urinary Tract Infections

Application of a Prediction Model for Directing Antibiotic Use in the Treatment of Urinary Tract Infection in an Ambulatory Setting

NCT06976125 · Urinary Tract Infections

RECRUITINGPhase 2

A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)

NCT05488340 · Urinary Tract Infections

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 2, 2020Terms

Trial snapshot

StatusTERMINATED

PhasePHASE4

Enrollment15

Start dateMay 2018

Last updatedSep 2, 2020

Condition

Urinary Tract Infections

Locations shown

Kantonsspital Aarau

Aarau

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 2, 2020Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions